Zevia: A High-Stakes Beverage Turnaround Poised on the Edge of Opportunity and Risk
Zevia PBC (ZVIA) is a beverage company operating at the intersection of consumer health consciousness and environmental responsibility. Structured as a Delaware public benefit corporation and a certified B Corp, the company is legally and philosophically committed to a dual mandate of generating shareholder returns while promoting positive social and environmental outcomes. Its core business revolves around a growing platform of "better-for-you" beverages that are zero-sugar, zero-calorie, and sweetened with plant-based ingredients, primarily stevia. The product portfolio spans several key beverage categories, including Soda, Energy Drinks, and Organic Teas, all of which are Non-GMO Project Verified and sold exclusively in aluminum cans, deliberately avoiding plastic bottles. Zevia's products are distributed across a broad network of major retailers in the United States and Canada, encompassing food, drug, mass-market, natural, and e-commerce channels.
The investment narrative for Zevia is a compelling, high-stakes turnaround story. The company's performance since its July 2021 Initial Public Offering (IPO) has been challenging, culminating in a difficult full-year 2024 that saw a net sales decline of $11.4 million to $155.0 million and a significant net loss of $23.8 million. However, recent results from the second quarter of 2025 signal a dramatic and potentially sustainable inflection point. In Q2 2025, Zevia reported a return to top-line growth with a 10.1% increase in net sales, driven by robust 14.3% volume growth. More critically, the company demonstrated significant operational leverage, expanding its gross profit margin by 680 basis points year-over-year to 48.7% and achieving a positive Adjusted EBITDA of $0.2 million—a stark improvement from the losses of prior periods. This suggests that management's strategic initiatives are beginning to yield tangible financial results.
Despite these encouraging signs, Zevia faces formidable challenges. The beverage industry is intensely competitive, with the company facing pressure from both legacy giants like Coca-Cola and PepsiCo and a constant stream of emerging brands. The business model is also characterized by significant concentration risks; a small number of retail customers account for a large portion of sales, and the company relies heavily on a few key suppliers for its raw materials and manufacturing. These dependencies create vulnerabilities in its supply chain and customer relationships. The opportunity, however, is equally significant. Zevia is well-positioned to capitalize on powerful secular consumer trends favoring healthier, cleaner-label products. The company's strategic pillars—focused on amplifying marketing, driving product innovation, expanding distribution, and delivering profitability—appear to be the right formula for navigating its challenges and capturing this opportunity. The investment thesis ultimately hinges on whether the impressive performance of Q2 2025 represents the beginning of a durable, profitable growth trajectory or merely a transient positive result in a historically volatile financial record.
Zevia's business model is predicated on capturing the growing consumer demand for healthier beverage alternatives. Its financial performance is directly influenced by a combination of sales volume, pricing strategy, and operational efficiency, all guided by a clear set of strategic initiatives.
The primary engine of Zevia's revenue is product sales volume, driven through its extensive distribution network that spans the entire retail landscape from mass-market stores to specialized natural food retailers and online platforms. The company's ability to increase the number of stores carrying its products (distribution breadth) and improve the rate at which those products sell off the shelves (sales velocity) is paramount. The 14.3% volume growth reported in Q2 2025 is a critical indicator of positive momentum, suggesting that the company's strategies to enhance both distribution and velocity are proving effective.
Revenue is also a function of the company's pricing and promotional architecture. The final net sales figure is determined by the wholesale price to retailers, less any discounts, slotting fees, and promotional allowances. While promotions can be a powerful tool to drive trial and increase volume, they can also compress margins. The company noted that the sales growth in Q2 2025 was achieved despite being partially offset by increased promotional activity, a dynamic that requires careful management to balance top-line growth with profitability. Successfully managing this trade-off is a key determinant of revenue quality and gross margin performance.
Under the leadership of CEO Amy Taylor, Zevia has articulated and is actively executing a multi-faceted strategy built on four distinct pillars. These pillars provide a clear framework for understanding the company's priorities and its path toward sustainable growth and profitability.
Amplify Marketing: The core of Zevia's brand strategy is to position itself as the authentic, "real" alternative in a market increasingly saturated with artificial ingredients. This involves a scaled marketing ecosystem that utilizes social media engagement, influencer partnerships, and targeted digital and audio advertising to build brand awareness and drive consumer purchase intent. The success of a "viral holiday campaign" in late 2024 serves as a tangible example of this strategy's potential to resonate with consumers and generate brand excitement.
Drive Product Innovation: Zevia is not simply relying on its existing product line but is actively innovating to meet evolving consumer tastes and create value for its retail partners. The recent launch of new flavors and formats has been a notable success. For instance, the introduction of variety packs has been so effective that they are now the top-selling Zevia SKU at Walmart, a critical retail partner. Furthermore, the launch of an exclusive Orange Creamsicle flavor at Sprouts has become the #1 selling Zevia product at that retailer. This approach of creating retailer-exclusive products and channel-specific SKUs demonstrates a sophisticated, data-driven strategy. It transforms the relationship with retailers from a simple transactional one to a collaborative partnership, where Zevia helps its retail customers win in the high-growth "better-for-you" category. This deepens the business relationship, encourages better data sharing, and ultimately creates stickier, more defensible shelf space.
Expand Distribution: A fundamental driver of future growth is getting Zevia products in front of more consumers. Management has stated that the company is actively "building distribution beyond historical peak levels," indicating a focused effort to expand its retail footprint. Securing placement in new stores and gaining additional shelf space within existing ones are direct pathways to incremental revenue and market share gains.
Deliver Profitability: Perhaps the most critical pillar in the company's turnaround has been its relentless focus on cost management and operational efficiency. The company's "Productivity Initiative" has been the primary engine behind its recent financial improvement. This program has already delivered $15 million in annualized cost savings, with management identifying an additional $5 million to be implemented in 2026. This initiative is directly responsible for the dramatic improvement in gross margin and was the key factor that enabled the company to achieve positive Adjusted EBITDA in Q2 2025, a crucial milestone on its path to sustainable profitability.
In a fiercely competitive market, Zevia leverages several key differentiators to carve out its niche.
Brand Authenticity and Mission: Zevia's legal status as a certified B Corp and a Public Benefit Corporation is a powerful competitive advantage. This is not merely a marketing designation but a legal commitment to balance the interests of shareholders with those of other stakeholders, including consumers, employees, and the environment. This structure reinforces the authenticity of its mission to improve global health, which resonates deeply with its target demographic of health-conscious and socially-aware consumers.
Clean Ingredient Profile: The company's unwavering commitment to a simple, plant-based ingredient list is a core differentiator. By using stevia as its primary sweetener and avoiding sugar, artificial sweeteners, and artificial colors, Zevia offers a "clean label" that stands out against many mainstream and diet beverage options. This appeals directly to the powerful consumer trend of ingredient transparency and avoidance of artificial additives.
First-Mover Advantage: Zevia was a pioneer in the naturally sweetened, zero-calorie soda category, claiming to be the first to use stevia in a carbonated soft drink. This history has endowed the brand with significant recognition and a loyal customer base within its niche, creating a foundation upon which it can build broader market appeal.
Zevia's financial narrative is one of sharp contrast between its challenging historical performance and a recent, dramatic operational turnaround. This inflection point is central to the investment thesis and is reflected in a valuation that offers significant potential for re-rating if recent improvements can be sustained.
An analysis of Zevia's financials reveals a clear pivot in performance between the end of fiscal year 2024 and the second quarter of 2025.
Fiscal Year 2024 was a period of significant difficulty for the company. Full-year net sales declined by $11.4 million to $155.0 million. While the gross profit margin improved slightly to 46.4%, the company remained deeply unprofitable, posting a net loss of $23.8 million, or a loss of $0.34 per share. On a non-GAAP basis, the Adjusted EBITDA loss for the year was $15.2 million, highlighting the operational challenges the company faced.
Second Quarter 2025 marked a stark and positive departure from this trend. The company announced a return to top-line growth, with net sales increasing 10.1% year-over-year to $44.5 million. The most critical development, however, occurred further down the income statement. Gross profit margin expanded by a remarkable 680 basis points to 48.7%, a direct result of the company's "Productivity Initiative" yielding lower product costs and better inventory management. This margin leverage was the primary driver that allowed Zevia to narrow its net loss to just $0.7 million, or a loss of $0.01 per share, and, most importantly, to achieve a positive Adjusted EBITDA of $0.2 million. The ability to generate positive cash flow from operations, even on an adjusted basis, fundamentally changes the company's financial profile and demonstrates a tangible path to sustainable profitability. The entire investment case for Zevia rests on the premise that this Q2 2025 performance is the new operational baseline and not a one-time event.
Zevia maintains a relatively clean balance sheet, which provides a degree of financial flexibility as it executes its turnaround. As of June 30, 2025, the company held $26.3 million in cash and cash equivalents. While this represents a modest decline from the $30.7 million held at the end of 2024, it is sufficient to fund near-term operations. The company carries minimal long-term debt, with total debt standing at approximately $1.1 million. Crucially, Zevia has access to an undrawn $20 million secured revolving credit facility, which provides a significant liquidity buffer should the need arise. The company's working capital position is healthy, with a current ratio of 2.34, indicating it has more than enough current assets to cover its short-term liabilities.
As of early September 2025, Zevia's market capitalization stands at approximately $195 million. Based on its last twelve months (LTM) of revenue of roughly $158 million, the company trades at a Price-to-Sales (P/S) multiple of approximately 1.2x. Its Price-to-Book (P/B) ratio is approximately 3.5x.
A comparison to peers in the beverage industry highlights Zevia's discounted valuation. This discount is a direct reflection of its history of unprofitability and the perceived execution risk associated with its turnaround. However, it also represents the core of the valuation opportunity. Should Zevia continue to deliver profitable growth, its valuation multiples could expand significantly to align more closely with those of its successful peers.
Source:
As the table illustrates, Zevia trades at a fraction of the valuation of both mature, highly profitable industry leaders like Coca-Cola and high-growth, profitable peers like Celsius and Vita Coco. This valuation gap presents a compelling opportunity if, and only if, the operational improvements demonstrated in Q2 2025 prove to be sustainable.
An investment in Zevia PBC carries a number of significant risks that must be carefully considered. These risks span operational execution, financial structure, and broad macroeconomic factors that could impact the company's performance.
Intense Competition: The non-alcoholic beverage market is one of the most competitive consumer segments globally. Zevia faces a multi-front war. On one side are the entrenched giants, The Coca-Cola Company and PepsiCo, which possess immense financial resources, unparalleled distribution networks, and massive marketing budgets. These incumbents are not idle; they are actively innovating and marketing their own zero-sugar and naturally sweetened product lines, directly targeting Zevia's core value proposition. On the other side is a dynamic and ever-changing landscape of smaller, emerging brands that constantly innovate on flavor, function, and marketing, vying for the same health-conscious consumer. Zevia's ability to maintain and grow its market share in this crowded field is a persistent and significant challenge.
Customer Concentration: Zevia's business is highly dependent on a small number of large retail partners. As disclosed in its Q2 2025 financial filings, two customers, "Customer J" and "Customer C," accounted for approximately 15% and 12% of net sales, respectively. The loss or significant reduction in shelf space from a key partner, such as Walmart or Costco, would have an immediate and material adverse effect on the company's revenue and financial condition. This concentration gives these large retailers substantial negotiating leverage over pricing and promotional terms.
Supplier Concentration: The company's supply chain exhibits a similar concentration risk. Zevia does not manufacture its own products, relying instead on a limited number of third-party co-packing facilities and raw material suppliers. Recent filings indicate that three specific vendors—D, E, and F—each individually represented between 31% and 37% of the company's raw material and finished goods purchases. Any disruption at one of these key suppliers—whether from operational issues, financial distress, or geopolitical events—could severely impair Zevia's ability to produce and deliver its products, leading to lost sales and damage to its brand reputation.
History of Net Losses: While the recent achievement of positive Adjusted EBITDA is a significant milestone, it is crucial to recognize that it represents a single quarter of performance. The company has a long history of generating net losses and has a substantial accumulated deficit, which stood at $127.3 million as of June 30, 2025. A sustained and proven track record of GAAP profitability has yet to be established, and there is no guarantee that the positive momentum from Q2 2025 will continue.
Tax Receivable Agreement (TRA) Liability: A complex and significant risk lies hidden within the company's financial disclosures. Zevia has a potential liability of $58.6 million related to a Tax Receivable Agreement (TRA) that is not currently recorded on its balance sheet. This liability is contingent upon the company becoming profitable enough to utilize its significant deferred tax assets (DTAs). The very event that forms the basis of the bull thesis—the achievement of sustained profitability—is the trigger that would cause this massive liability to be recognized as an expense on the income statement. This creates a challenging dynamic where future success will be accompanied by a significant charge to earnings, diverting a substantial portion of value created away from common shareholders. At $58.6 million, this potential liability represents approximately 30% of the company's current market capitalization, making it a material headwind that is likely underappreciated by the market.
Inflation and Input Costs: Zevia's profitability is directly exposed to inflationary pressures across its supply chain. The costs of raw ingredients (including stevia), aluminum for cans, transportation, and labor can be volatile and have a direct impact on its cost of goods sold and, therefore, its gross margin.
Tariffs and Trade Policy: The company's risk factors explicitly identify the adverse impact of tariffs on its business. Specifically, tariffs imposed on steel and aluminum imports have directly increased the cost of its primary packaging material—aluminum cans. The company has stated that these tariffs have increased its cost of goods sold and expects this pressure to continue. Any further escalation in trade disputes or the imposition of new tariffs represents a direct and quantifiable threat to the company's margin expansion story.
Consumer Spending Patterns: As a product that often commands a premium price relative to conventional sodas, Zevia is vulnerable to shifts in consumer discretionary spending. During periods of economic weakness or high inflation, consumers may become more price-sensitive and "trade down" to lower-cost private label or incumbent brands, which could negatively impact Zevia's sales volume and market share.
This forward-looking analysis projects Zevia's potential total return over a five-year horizon, from fiscal year-end 2024 through fiscal year-end 2029. The methodology is driven by fundamental business assumptions regarding revenue growth, margin evolution, and operating leverage. The current share price as of September 9, 2025, is $2.49 , but this analysis derives its price targets independently from this starting point. The terminal valuation in Year 5 (FY2029) is based on an Enterprise Value-to-Sales (EV/Sales) multiple, a standard metric for companies in a growth phase where profitability is still maturing.
Subjective Probability: 50%
Fundamental Drivers: This scenario assumes that the operational turnaround demonstrated in Q2 2025 is sustained. Management successfully executes its strategic plan, leading to consistent, albeit moderating, growth. Revenue is projected to grow at a compound annual growth rate (CAGR) of 10%, driven by continued distribution gains and successful product innovation. The benefits of the Productivity Initiative are realized, allowing gross margins to stabilize in the 49% to 50% range. As the business scales, it achieves operating leverage, resulting in consistent, low single-digit operating margins by the third year of the forecast period.
Valuation and Outcome: Reflecting its status as a more stable and consistently profitable entity, a terminal EV/Sales multiple of 1.5x is applied to the projected FY2029 revenue. This multiple represents a modest premium to its current discounted valuation. Based on these assumptions, the projected share price in five years is $5.10.
Subjective Probability: 25%
Fundamental Drivers: In this optimistic scenario, Zevia capitalizes fully on the secular shift toward healthier beverages and establishes itself as a clear leader in the naturally sweetened soda category. Aggressive and successful marketing campaigns, coupled with major new distribution wins, fuel a revenue CAGR of 20%. Economies of scale in purchasing and manufacturing, along with continued efficiency gains, allow gross margins to expand to 52%. The company achieves significant operating leverage, with selling, general, and administrative (SG&A) expenses growing much slower than revenue, leading to high single-digit operating margins by Year 4.
Valuation and Outcome: The company's strong growth profile and solid profitability would command a premium valuation. A terminal EV/Sales multiple of 2.5x is applied to FY2029 revenue, placing it closer to the multiples of other successful high-growth beverage companies. This scenario results in a projected five-year share price of $13.25.
Subjective Probability: 25%
Fundamental Drivers: This scenario envisions a failure to maintain the momentum of Q2 2025. Intense competitive pressure from both large incumbents and nimble new entrants forces Zevia into a cycle of heavy promotional spending to defend its shelf space. This erodes profitability and brand equity. Revenue growth stagnates, averaging only a 3% CAGR. Gross margins compress back toward the 44% to 45% level as cost savings are offset by promotions and rising input costs. The company struggles to achieve consistent profitability and may experience periods of cash burn.
Valuation and Outcome: The market would likely assign a distressed valuation to a stagnant, unprofitable business in a competitive industry. A terminal EV/Sales multiple of 0.8x is applied to FY2029 revenue, a discount to its current multiple. This leads to a projected five-year share price of $1.80, representing a negative return from the current price.
The probability-weighted price target synthesizes the outcomes of the three scenarios into a single expected value.
Calculation: ($13.25 \times 0.25) + ($5.10 \times 0.50) + ($1.80 \times 0.25) = $3.3125 + $2.55 + $0.45
Probability-Weighted 5-Year Price Target: $6.31
This target suggests a significant potential upside from the current share price, reflecting the asymmetric risk-reward profile of this turnaround investment.
RISKED REWARD
This scorecard provides a qualitative assessment of Zevia across ten critical factors, each rated on a scale of 1 to 10. The narrative for each score is based on a holistic review of the company's filings, strategic positioning, and financial health.
Management Alignment (Score: 3/10): A low score here is primarily driven by recent insider trading activity. While CEO Amy Taylor's direct ownership of 0.52% of the company is a positive, it is overshadowed by significant and consistent selling from insiders. Over the past year, insiders have been net sellers of nearly 4 million shares. This includes a 2-million-share sale by a major 10% beneficial owner, Caisse de Dépôt et Placement du Québec, as well as sales by the CEO and other officers. This pattern of selling, particularly following a period of stock price appreciation, can signal a lack of long-term conviction from those who know the company best and creates a negative perception in the market.
Revenue Quality (Score: 6/10): Zevia's revenue is derived from the sale of consumer-packaged goods through established retail channels, which provides a recurring and relatively predictable base. However, the quality of this revenue is tempered by two key factors. First, the high degree of customer concentration, with two retailers accounting for approximately 27% of sales, creates a dependency risk. Second, the reliance on promotional activity to drive volume can lead to lumpiness in quarterly results and pressure on gross margins, making the top line less "pure" than that of a brand with stronger pricing power.
Market Position (Score: 5/10): Zevia holds a respectable and well-recognized position within the niche, but rapidly growing, "naturally sweetened" beverage category. It benefits from its first-mover status and strong brand identity. However, in the broader context of the global beverage market, it is a minuscule player facing formidable competition from behemoths like Coca-Cola and PepsiCo, who possess overwhelming scale advantages. The recent return to volume growth is a positive sign that it is defending its turf, but its long-term ability to win sustained share from larger rivals remains an open question.
Growth Outlook (Score: 7/10): The company is exceptionally well-positioned to benefit from powerful, long-term secular tailwinds related to consumer health and wellness. The recent operational success, including a return to double-digit volume growth and distribution expansion beyond prior peaks, demonstrates that its strategy is resonating in the marketplace. Analyst consensus forecasts also point to continued revenue growth in the coming years. The growth outlook is strong, but it is contingent on continued flawless execution in a difficult market.
Financial Health (Score: 5/10): Zevia's balance sheet is a source of stability. With minimal debt and access to an undrawn $20 million credit facility, the company has adequate liquidity to fund its operations and growth initiatives in the near term. However, this score is constrained by the company's history of negative operating cash flow and net losses. Furthermore, the large, off-balance-sheet TRA liability of $58.6 million represents a significant future claim on the company's cash flows, which detracts from its overall financial strength.
Business Viability (Score: 6/10): The achievement of positive Adjusted EBITDA in Q2 2025 was a watershed moment for the company's perceived viability. It provided the first piece of concrete evidence that the business model can generate cash flow and that a path to sustainable profitability exists. Prior to this result, the company's long-term viability was a significant concern for investors. The score remains moderated because this performance must be sustained over multiple quarters to be considered the new norm.
Capital Allocation (Score: 4/10): As a relatively young public company that has been focused on growth and achieving profitability, Zevia has a limited track record in capital allocation. The company does not pay a dividend and does not have a share repurchase program. Capital is primarily reinvested into the business to fund marketing and innovation. The recent disclosure of an equity distribution agreement, which allows the company to sell up to $20 million in stock, signals a potential need for external capital, which would be dilutive to existing shareholders at current prices.
Analyst Sentiment (Score: 7/10): Wall Street sentiment is broadly positive and has been improving. The consensus rating among analysts is a "Buy," with an average one-year price target in the range of $4.61 to $4.96, suggesting substantial upside from the current share price. However, the presence of several "Hold" ratings and a wide dispersion in price targets indicates a degree of uncertainty and debate among analysts regarding the company's prospects.
Profitability (Score: 3/10): Zevia's historical profitability metrics are poor. The company has a long track record of GAAP net losses and negative operating margins. The score is lifted from a lower level solely on the basis of the single quarter of positive Adjusted EBITDA in Q2 2025. Until the company can demonstrate a consistent ability to generate positive GAAP net income, its profitability will remain a key weakness.
Track Record (Score: 2/10): Since its IPO in July 2021, Zevia has a poor track record of creating shareholder value. The stock priced at $14 per share and has since declined precipitously, with its market capitalization falling from over $469 million to its current level below $200 million. For early investors, the company has been an instrument of significant capital destruction. There is no history of positive shareholder value creation to date.
PROVE IT STORY
The investment case for Zevia PBC is that of a classic turnaround story, offering a high-risk, high-reward profile that hinges entirely on the durability of its recent operational success. The company's future is balanced on a knife's edge between the powerful secular tailwinds of consumer health trends and the formidable headwinds of intense competition and historical financial weakness.
The outlook for Zevia has improved dramatically following its second-quarter 2025 results. The company delivered a "beat and raise" quarter that showcased a return to robust volume growth, remarkable gross margin expansion, and the critical achievement of positive Adjusted EBITDA. This performance was not accidental; it was the direct result of a well-articulated and effectively executed four-pillar strategy focused on marketing, innovation, distribution, and cost discipline. For the first time since its IPO, there is tangible evidence of a viable path to sustainable, profitable growth. The key question for investors is whether this quarter represents a new fundamental reality for the company or a temporary high point.
An investment in Zevia today is an explicit bet that the operational and financial improvements demonstrated in the second quarter of 2025 are the new baseline for the business. The current valuation, with a Price-to-Sales multiple of approximately 1.2x, reflects a market that is still pricing the company based on its history of unprofitability and execution challenges. If management can prove its ability to consistently execute its strategy—continuing to grow the top line through innovative products and expanded distribution while maintaining the cost discipline that has transformed its margin profile—the company is significantly undervalued. The bull case posits that as Zevia delivers consecutive quarters of profitable growth, its valuation multiple will re-rate upwards, converging towards the levels of other successful beverage growth stories and delivering a multi-bagger return to shareholders over a five-year horizon.
Sustained Profitability: The most important catalyst would be the reporting of consecutive quarters of positive Adjusted EBITDA, which would build market confidence and provide a clear line of sight to sustained GAAP profitability.
Major Distribution Wins: The announcement of a significant new national retail partnership or a material expansion of shelf space and product offerings within existing key partners like Walmart or Costco would validate the growth story.
Successful Product Launches: The introduction of a new product line or flavor that gains significant market traction would demonstrate the company's continued ability to innovate and could serve as a new engine for growth.
Execution Missteps: The primary risk is a relapse into old habits. A failure to maintain the recent margin improvements or a return to negative top-line growth would severely damage management's credibility and likely cause the stock to fall to new lows.
Competitive Response: An aggressive pricing war or a highly successful new product launch from a major competitor like Coca-Cola or PepsiCo could blunt Zevia's momentum and make it difficult to gain or hold market share.
Insider and Institutional Selling: The pattern of significant insider selling is a major red flag. Continued large-scale selling from insiders or major institutional holders could signal a lack of long-term confidence and create a persistent technical overhang on the stock price.
Macroeconomic Headwinds: A sharp economic recession that leads to consumer trade-down, or a new wave of tariffs on key inputs like aluminum, could simultaneously pressure Zevia's revenue and its margins.
TURNAROUND GAMBLE
From a technical standpoint, Zevia's stock remains in a challenging position despite recent fundamental improvements. The current share price of $2.49 is trading well below its 200-day simple moving average, which stands near $2.95-$2.99. This configuration indicates that the stock's long-term trend is still bearish. Following the strong Q2 2025 earnings report on August 6, the stock experienced a sharp rally to $3.44, but it was unable to hold these gains and has since retraced back below key moving averages, including the 50-day moving average of around $2.68. The short-term outlook is therefore neutral to bearish; the price action suggests market skepticism persists, and for a bullish trend to emerge, the stock must decisively reclaim and hold above both its 50-day and 200-day moving averages.
TECHNICALLY WEAK
View Zevia PBC (ZVIA) stock page
Loading the interactive version of this report…